Officials from CMUH and patient Chang. Credit: PRNewswire/China Medical University Hospital.

China Medical University Hospital (CMUH) has developed a new home-based system, Intelligent Detection of Respiratory Events through Automated Monitoring (iDREAM), for detecting sleep apnoea.

The device utilises AI to accurately detect severe obstructive sleep apnoea syndrome (OSAS) during sleep sessions at home.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Featuring Quanta’s QOCA Portable ECG Monitoring Device, the iDREAM system has demonstrated a 95.8% accuracy rate for identifying severe OSAS.

CMUH laryngology director Dr Yung-An Tsou highlighted the prevalence of sleep disorders in Taiwan, affecting more than 20% of the population. iDREAM aims to address this by providing an accessible and efficient diagnostic tool.

The clinical trials of iDREAM involving over 100 patients have shown promising results.

As part of the trial, Chang, a patient with severe snoring issues, underwent uvulopalatopharyngoplasty (UPPP) and was subsequently monitored using iDREAM.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

This portable device transmitted records to a cloud server, where ECG data was rapidly analysed by an AI model powered by extensive datasets.

Following treatment, Chang experienced significant relief from sleep apnoea and a notable improvement in sleep quality.

The home-based sleep detection system identifies ECG alterations during episodes of OSAS and assesses severity through its advanced deep learning approach.

It boasts accuracy rates of 92.7% and 93.2% for detecting sleep apnoea and wake-up events (indicating sleep interruption from apnoea), respectively.

While still undergoing clinical testing, iDREAM is poised to seek certification from the Taiwan Food and Drug Administration as a smart medical device, paving the way for its formal integration into clinical practice.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact